NEW YORK (GenomeWeb News) — Merck last week closed its $1.1 billion acquisition of Sirna Therapeutics, but not before the RNAi shop managed to tentatively muzzle a trio of shareholder-led lawsuits accusing its brass of double-dealing in their negotiations with Merck, according to a filing with the Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.

Sponsored by

This webinar will cover recent advances in the use of CRISPR for generating animal models and cell lines.